We observed that although the activation pathways (broken red arrows)from SMO to GLI1 and GLI2 via STK36 protein were blocked by the effect of SMO inhibitor in each cancer scenario, HFU could also activate GLI1 and GLI2 in each cancer scenario (solid green arrows). The gene discussed is GLI2; the disease is cancer.